scholarly journals Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies

RSC Advances ◽  
2020 ◽  
Vol 10 (59) ◽  
pp. 35820-35830 ◽  
Author(s):  
Hatem A. Abuelizz ◽  
Mohamed Marzouk ◽  
Ahmed H. Bakheit ◽  
Rashad Al-Salahi

HCV NS3/A4 protease inhibitors are one of the best therapeutic targets for the identification of novel candidate drugs. A series of benzo[g]quinazolines and their quinazoline analogues were evaluated for their HCV-NS3/4A inhibitory activities.

2010 ◽  
Vol 16 (7) ◽  
pp. 1251-1268 ◽  
Author(s):  
Vijay M. Khedkar ◽  
Premlata K. Ambre ◽  
Jitender Verma ◽  
Mushtaque S. Shaikh ◽  
Raghuvir R. S. Pissurlenkar ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Fariba Peytam ◽  
Ghazaleh Takalloobanafshi ◽  
Toktam Saadattalab ◽  
Maryam Norouzbahari ◽  
Zahra Emamgholipour ◽  
...  

AbstractIn an attempt to find novel, potent α-glucosidase inhibitors, a library of poly-substituted 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines 3a–ag have been synthesized through heating a mixture of 2-aminobenzimidazoles 1 and α-azidochalcone 2 under the mild conditions. This efficient, facile protocol has been resulted into the desirable compounds with a wide substrate scope in good to excellent yields. Afterwards, their inhibitory activities against yeast α-glucosidase enzyme were investigated. Showing IC50 values ranging from 16.4 ± 0.36 µM to 297.0 ± 1.2 µM confirmed their excellent potency to inhibit α-glucosidase which encouraged us to perform further studies on α-glucosidase enzymes obtained from rat as a mammal source. Among various synthesized 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines, compound 3k exhibited the highest potency against both Saccharomyces cerevisiae α-glucosidase (IC50 = 16.4 ± 0.36 μM) and rat small intestine α-glucosidase (IC50 = 45.0 ± 8.2 μM). Moreover, the role of amine moiety on the observed activity was studied through substituting with chlorine and hydrogen resulted into a considerable deterioration on the inhibitory activity. Kinetic study and molecular docking study have confirmed the in-vitro results.


2020 ◽  
Vol 5 (48) ◽  
pp. 15243-15253
Author(s):  
Walaa S. El‐serwy ◽  
Hanaa S. Mohamed ◽  
Weam S. El‐serwy ◽  
Neama A. Mohamed ◽  
Emad M. M. Kassem ◽  
...  

2013 ◽  
Vol 61 (28) ◽  
pp. 6776-6785 ◽  
Author(s):  
Khodayar Gholivand ◽  
Ali Asghar Ebrahimi Valmoozi ◽  
Hamid R. Mahzouni ◽  
Saied Ghadimi ◽  
Rayhaneh Rahimi

2016 ◽  
Vol 121 ◽  
pp. 410-421 ◽  
Author(s):  
Alaa A.-M. Abdel-Aziz ◽  
Laila A. Abou-Zeid ◽  
Kamal Eldin H. ElTahir ◽  
Rezk R. Ayyad ◽  
Magda A.-A. El-Sayed ◽  
...  

Author(s):  
Bin Chong ◽  
Yingguang Yang ◽  
Zi-Le Wang ◽  
Han Xing ◽  
Zhirong Liu

Intrinsically disordered proteins (IDPs) widely involve in human diseases and are thus attractive therapeutic targets. In practice, however, it is computationally prohibitive to dock large ligand libraries to thousands and...


2014 ◽  
Vol 9 (3) ◽  
Author(s):  
Muhammad Tahir Ul Qamar ◽  
Arooj Mumtaz ◽  
Usman Ali Ashfaq ◽  
Muhammad Muzammal Adeel ◽  
Tabeer Fatima

Sign in / Sign up

Export Citation Format

Share Document